STAT

JULY 2, 2024

These medications don’t have to be so expensive, but all too often pharmaceutical companies use illegal tactics to block competition that could lower prices and encourage innovation. Americans are facing an affordability crisis at the hands of corporate titans. Read the rest…

Pharmaceutical Companies 362

Pharmaceutical Companies Pharmaceutical Companies Drug Development 362

STAT

SEPTEMBER 26, 2022

In an effort to sway the Food and Drug Administration not to withdraw accelerated approval of Makena, a drug developed to prevent preterm birth that does no such thing, a pharmaceutical company owned by a private equity company is making the specious argument that the drug should be kept on the market because it may — the emphasis is mine — (..)

Pharmaceutical Companies 263

Pharmaceutical Companies Pharmaceutical Companies Drug Development 263

Drug Patent Watch

NOVEMBER 19, 2024

The pharmaceutical industry is undergoing significant transformations, particularly in the realm of generic drug development. Recent trends and advancements in technology, research, and collaboration are reshaping the landscape of generic drug development, leading to new opportunities and challenges for pharmaceutical companies.

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies 105

STAT

OCTOBER 4, 2022

The press release issued by pharmaceutical companies Eisai and Biogen on Sept. Years and years of failed Alzheimer’s trials created, and then fortified , doubts about whether drugs that attacked amyloid, a brain protein linked to Alzheimer’s disease, were a valid approach to its treatment.

Pharmaceutical Companies 328

Pharmaceutical Companies Pharmaceutical Companies Drug Development 328

STAT

APRIL 18, 2024

A leading animal rights group has asked securities regulators to investigate Charles River Laboratories for allegedly misleading investors about its sales and purchases of long-tailed macaques, which are widely used in clinical research by pharmaceutical companies and universities, among others.

Labelling 351

Labelling Pharmaceutical Companies Pharmaceutical Companies Drug Development 351

European Pharmaceutical Review

JUNE 27, 2022

DRUG DEVELOPMENT based on targeted protein degradation (TPD) has progressed rapidly since the publication in 2015 of three landmark papers 1-3 that highlighted important early-stage breakthroughs with drug-like molecules in this area of research.

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies 105

STAT

OCTOBER 5, 2023

Some scientists are trying to calculate those footprints, as part of a growing effort to understand biotech and pharmaceutical companies’ contributions to climate change. What if that information also included your medicine’s carbon footprint?

Pharmaceutical Companies 341

Pharmaceutical Companies Pharmaceutical Companies Drug Development 341

STAT

FEBRUARY 29, 2024

CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols. Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services.

Pharmaceutical Companies 353

Pharmaceutical Companies Pharmaceutical Companies Drug Development 353

STAT

MAY 22, 2024

A 2024 analysis of drugs included in this program showed they had 23% shorter clinical development timelines than those that were not part of the program, with no negative effects on their safety profiles.

Pharmaceutical Companies 300

Pharmaceutical Companies Pharmaceutical Companies Drug Development 300

European Pharmaceutical Review

SEPTEMBER 12, 2023

Initial data from the CPHI Annual Report 2023, which provides insight from 250 global pharmaceutical companies, reveals that AI (artificial intelligence) is expected to transform every area of the industry, from drug discovery through to drug development , within the next 24-months. Attending CPHI Barcelona 2023?

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies 105

STAT

DECEMBER 6, 2024

The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the largest pharmaceutical companies, would pay $16.5 billion for Catalent, a leading contract drug manufacturer.

Pharmaceutical Companies 281

Pharmaceutical Companies Pharmaceutical Companies Drug Development 281

STAT

OCTOBER 15, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. 

Pharmaceutical Companies 262

Pharmaceutical Companies Pharmaceutical Companies Drug Development 262

Drug Patent Watch

DECEMBER 10, 2024

This shift has led to the emergence of integrated contract development and manufacturing organizations (CDMOs), which provide end-to-end support for drug developers. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48 from 2023 to 2030.

Drug Development 59

Drug Development Communication Pharmaceutical Companies Pharmaceutical Companies 59

STAT

JULY 12, 2023

These medicines, colloquially called “n of 1” therapies, are often made to treat debilitating genetic conditions that are too rare to garner interest from pharmaceutical companies. Read the rest…

Pharmaceutical Companies 246

Pharmaceutical Companies Pharmaceutical Companies Drug Development 246

STAT

JANUARY 19, 2023

In a stunning rebuke, the Food and Drug Administration accused a drugmaker of a “cascade of failures” for a litany of quality-control problems at a manufacturing plant, the latest instance in which the regulator has castigated an Indian pharmaceutical company for such lapses.

Documentation 246

Documentation Pharmaceutical Companies Pharmaceutical Companies Drug Development 246

STAT

MARCH 7, 2023

But he also said he saw it as an example of a drug company filling the void left by health systems that aren’t teaching doctors and trainees how to use new medicines. Continue to STAT+ to read the full story…

Medical Schools 246

Medical Schools Pharmaceutical Companies Pharmaceutical Companies Drug Development 246

STAT

NOVEMBER 15, 2022

For the first time, many of the world’s largest pharmaceutical companies are taking concrete steps to widen access to their medicines in low and middle-income countries, but the poorest countries continue to be disproportionately overlooked, according to a new analysis.

Pharmaceutical Companies 245

Pharmaceutical Companies Pharmaceutical Companies Drug Development 245

STAT

OCTOBER 3, 2022

Food and Drug Administration established in 1982 in an effort to get medicines for hard-to-treat diseases to patients sooner than they might under the usual pathways to the marketplace. As a condition of approval, a pharmaceutical company must confirm the effectiveness of its medicine through one or more clinical trials by a certain date.

Pharmaceutical Companies 234

Pharmaceutical Companies Pharmaceutical Companies Drug Development 234

pharmaphorum

DECEMBER 21, 2021

During the course of the webinar, Keefer explained how specialty sites, with deep knowledge on one or certain groups of Rare Diseases, are crucial for further progress in drug development to progress the number of treatments available to Rare Disease patients and to provide support to those individuals.

Drug Development 98

Drug Development Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

Drug Patent Watch

OCTOBER 28, 2024

The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to streamline the drug development and manufacturing process. Here are the top 10 CDMO services you might not have known you needed… Source

Pharmaceutical Companies 109

Pharmaceutical Companies Pharmaceutical Companies Drug Development 109

STAT

DECEMBER 9, 2024

Well, in Dimension’s case, they end up investing in some buzzy AI startups, counseling pharmaceutical companies, ribbing one another about expense reports, and — as of Monday — are able to raise $500 million for their second fund.

Pharmaceutical Companies 301

Pharmaceutical Companies Pharmaceutical Companies Drug Development 301

STAT

DECEMBER 19, 2024

Access to cheaper alternatives and low enrollment prompted the company to remove the medicine — along with the HIV medicines Emtriva, Tybost, and Complera — from its patent assistance program next month, according to an Oct. 8 letter that announced the move and that has not been widely reported.

Pharmaceutical Companies 206

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing Drug Development 206

Express Pharma

JULY 8, 2024

Shanghai Fosun Pharmaceutical to acquire the remaining stake in Shanghai Henlius Biotech, a biopharmaceutical company, for a consideration of approximately $692.5 million; NewGenIvf Group, to acquire COVIRIX Medical, a clinical-stage pharmaceutical company developing novel antiviral therapies for $617.3

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

STAT

DECEMBER 13, 2024

This isn’t just a drug approval, but a major strategic shift. For more than 30 years, Ionis developed all of its medicines in partnership with large pharmaceutical companies. Peak sales could reach $2 billion in 2035, according to Wolfe Research, a sell-side research firm. This time, it is standing alone.

Pharmaceutical Companies 182

Pharmaceutical Companies Pharmaceutical Companies Drug Development 182

European Pharmaceutical Review

NOVEMBER 14, 2023

Outsourcing regulatory activities in pharma Here, EPR’s Editor explores some key considerations, approaches and strategies for pharmaceutical companies looking to outsource regulatory activities.

Drug Development 98

Drug Development Pharmaceutical Companies Pharmaceutical Companies 98

STAT

DECEMBER 13, 2024

Just 9% came from the private sector, such as pharmaceutical companies. Looked at another way, the public sector provided 62% of the $1.2 billion in funding, followed by philanthropies that contributed 24%. Continue to STAT+ to read the full story…

Pharmaceutical Companies 141

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Pricing 141

Express Pharma

JUNE 11, 2024

With the evolving landscape of drug development and innovations, several institutes are serving as catalysts by partnering with pharmaceutical companies to drive progress at various stages of research and development.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Drug Development Compounding 105

Outsourcing Pharma

SEPTEMBER 12, 2024

Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligenceâs (AI's) potential to transform drug development.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Drug Development 59

Pharmaceutical Technology

JUNE 15, 2023

The need for new medical treatments and drugs has never been greater. But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S.

Drug Development 52

Drug Development Compounding Adverse Reactions Dosage 52

European Pharmaceutical Review

OCTOBER 11, 2022

The study produced by the University of Cambridge has indicated that pharmaceutical companies are increasingly leaning away from one-time transactions with contract research organisations (CRO), to preferred providers and multi-year strategic partnerships. billion to develop and manufacture one drug.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Drug Development 98

Pharma Marketing Network

JULY 26, 2023

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. However, in recent years, there has been a noticeable decline in the number of these letters being issued.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Labelling Drug Development 97

European Pharmaceutical Review

JUNE 7, 2024

Pharmaceutical companies ask themselves this question before embracing the latest technologies because every innovation comes with both opportunities and risks. According to recent estimates, the opportunity from generative AI alone could produce up to $110 billion in annual value across the pharmaceutical industry value chain.

Health and Personal Care Stores 113

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Drug Development 113

Drug Patent Watch

AUGUST 26, 2024

The pharmaceutical industry has increasingly relied on Contract Development and Manufacturing Organizations (CDMOs) to support the development and commercialization of drugs. CDMOs offer a range of services, from drug development to manufacturing, allowing pharmaceutical companies to focus on their core competencies.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Drug Development 59

European Pharmaceutical Review

DECEMBER 21, 2023

AMGS minimisation could have widespread implications for drug development research” This AMGS minimisation could have “widespread implications” for drug development research and other production fields reliant on separation sciences, the researchers stated.

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

NOVEMBER 9, 2023

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders.

Drug Development 115

Drug Development Immunity Immunization Pharmaceutical Companies 115

European Pharmaceutical Review

MAY 17, 2023

FDA publishes paper on AI/ML in drug development In 2022, North America had the largest revenue share in the global pharmaceutical quality management systems market, according to the report. These solutions eliminate the need for on-premise servers and hardware, reducing IT infrastructure costs for pharmaceutical companies.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Drug Development 98

PharmaTech

JANUARY 9, 2024

Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals, highlights traits that a (bio)pharmaceutical company look for when identifying a CDMO to support drug development and manufacturing programs.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52